-
1
-
-
84055213663
-
Adult hippocampal neurogenesis and its role in Alzheimer's disease
-
Mu Y, Gage FH: Adult hippocampal neurogenesis and its role in Alzheimer's disease. Mol Neurodegener 2011; 6: 85-94.
-
(2011)
Mol Neurodegener
, vol.6
, pp. 85-94
-
-
Mu, Y.1
Gage, F.H.2
-
2
-
-
0026847039
-
Memory and the hippocampus: A synthesis from findings with rats, monkeys, and humans
-
Squire L: Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychol Rev 1992; 99: 195-231.
-
(1992)
Psychol Rev
, vol.99
, pp. 195-231
-
-
Squire, L.1
-
3
-
-
0031052381
-
Amyloid, the presenilins and Alzheimer's disease
-
Hardy J: Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci 1997; 20: 154-159.
-
(1997)
Trends Neurosci
, vol.20
, pp. 154-159
-
-
Hardy, J.1
-
4
-
-
0141552123
-
Aging of the brain and dementia of the Alzheimer type
-
Kandel ER SJ, Jessel TM (eds):. New York, McGraw-Hill
-
Price DL: Aging of the brain and dementia of the Alzheimer type; in Kandel ER SJ, Jessel TM (eds): Principles of Neural Science. New York, McGraw-Hill, 2000, pp 1149-1161.
-
(2000)
Principles of Neural Science
, pp. 1149-1161
-
-
Price, D.L.1
-
5
-
-
33947493213
-
Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: Minding the store
-
Thibault O, Gant JC, Landfield PW: Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the store. Aging Cell 2007; 6: 307-317.
-
(2007)
Aging Cell
, vol.6
, pp. 307-317
-
-
Thibault, O.1
Gant, J.C.2
Landfield, P.W.3
-
6
-
-
0033393340
-
L-type calcium channels in the hippocampus and cerebellum of Alzheimer's disease brain tissue
-
Coon A, Wallace DR, Mactutus CF, Booze RM: L-type calcium channels in the hippocampus and cerebellum of Alzheimer's disease brain tissue. Neurobiol Aging 1999; 20: 597-603.
-
(1999)
Neurobiol Aging
, vol.20
, pp. 597-603
-
-
Coon, A.1
Wallace, D.R.2
Mactutus, C.F.3
Booze, R.M.4
-
7
-
-
67349222799
-
Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and disease
-
Cekic M, Sayeed I, Stein DG: Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and disease. Front Neuroendocrinol 2009; 30: 158-172.
-
(2009)
Front Neuroendocrinol
, vol.30
, pp. 158-172
-
-
Cekic, M.1
Sayeed, I.2
Stein, D.G.3
-
8
-
-
10044272155
-
Distribution of the vitamin D receptor and 1 alphahydroxylase in human brain
-
Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ: Distribution of the vitamin D receptor and 1 alphahydroxylase in human brain. J Chem Neuroanat 2005; 29: 21-30.
-
(2005)
J Chem Neuroanat
, vol.29
, pp. 21-30
-
-
Eyles, D.W.1
Smith, S.2
Kinobe, R.3
Hewison, M.4
McGrath, J.J.5
-
9
-
-
0036550614
-
New clues about vitamin D functions in the nervous system
-
Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D: New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 2002; 13: 100-105.
-
(2002)
Trends Endocrinol Metab
, vol.13
, pp. 100-105
-
-
Garcion, E.1
Wion-Barbot, N.2
Montero-Menei, C.N.3
Berger, F.4
Wion, D.5
-
10
-
-
71449103001
-
Vitamin D, a neuro-immunomodulator: Implications for neurodegenerative and autoimmune diseases
-
Fernandes de Abreu DA, Eyles D, Féron F: Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology 2009; 34(suppl 1):S265-S277.
-
(2009)
Psychoneuroendocrinology
, vol.34
, pp. S265-S277
-
-
Fernandes De Abreu, D.A.1
Eyles, D.2
Féron, F.3
-
11
-
-
77953946274
-
Vitamin D: Metabolism
-
Christakos S, Ajibade DV, Dhawan P, Fechner AJ, Mady LJ: Vitamin D: metabolism. Endocrinol Metab Clin North Am 2010; 39: 243-253.
-
(2010)
Endocrinol Metab Clin North Am
, vol.39
, pp. 243-253
-
-
Christakos, S.1
Ajibade, D.V.2
Dhawan, P.3
Fechner, A.J.4
Mady, L.J.5
-
12
-
-
77955475502
-
Novel regulation of 25-hydroxyvitamin D3 24-hydroxylase (24(OH)ase) transcription by glucocorticoids: Cooperative effects of the glucocorticoid receptor, C/EBP beta, and the vitamin D receptor in 24(OH)ase transcription
-
Dhawan P, Christakos S: Novel regulation of 25-hydroxyvitamin D3 24-hydroxylase (24(OH)ase) transcription by glucocorticoids: cooperative effects of the glucocorticoid receptor, C/EBP beta, and the vitamin D receptor in 24(OH)ase transcription. J Cell Biochem 2010; 110: 1314-1323.
-
(2010)
J Cell Biochem
, vol.110
, pp. 1314-1323
-
-
Dhawan, P.1
Christakos, S.2
-
13
-
-
84883192606
-
Vitamin D inquiry in hippocampal neurons: Consequences of vitamin D-VDR pathway disruption on calcium channel and the vitamin D requirement
-
E-pub ahead of print
-
Gezen-Ak D, Dursun E, Yilmazer S: Vitamin D inquiry in hippocampal neurons: consequences of vitamin D-VDR pathway disruption on calcium channel and the vitamin D requirement. Neurol Sci 2012, E-pub ahead of print.
-
(2012)
Neurol Sci
-
-
Gezen-Ak, D.1
Dursun, E.2
Yilmazer, S.3
-
14
-
-
0026597610
-
Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: Correlation with calbindin-28k mRNA levels
-
Sutherland MK, Somerville MJ, Yoong LK, Bergeron C, Haussler MR, McLachlan DR: Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels. Brain Res Mol Brain Res 1992; 13: 239-250.
-
(1992)
Brain Res Mol Brain Res
, vol.13
, pp. 239-250
-
-
Sutherland, M.K.1
Somerville, M.J.2
Yoong, L.K.3
Bergeron, C.4
Haussler, M.R.5
McLachlan, D.R.6
-
15
-
-
0035860474
-
Chromosome 12 and late onset Alzheimer's disease
-
Poduslo SE, Yin X: Chromosome 12 and late onset Alzheimer's disease. Neurosci Lett 2001; 310: 188-190.
-
(2001)
Neurosci Lett
, vol.310
, pp. 188-190
-
-
Poduslo, S.E.1
Yin, X.2
-
16
-
-
34548051122
-
Association between vitamin D receptor gene polymorphism and Alzheimer's disease
-
Gezen-Ak D, Dursun E, Ertan T, Hanagasi H, Gurvit H, Emre M, Eker E, Ozturk M, Engin F, Yilmazer S: Association between vitamin D receptor gene polymorphism and Alzheimer's disease. Tohoku J Exp Med 2007; 212: 275-282.
-
(2007)
Tohoku J Exp Med
, vol.212
, pp. 275-282
-
-
Gezen-Ak, D.1
Dursun, E.2
Ertan, T.3
Hanagasi, H.4
Gurvit, H.5
Emre, M.6
Eker, E.7
Ozturk, M.8
Engin, F.9
Yilmazer, S.10
-
17
-
-
58549111852
-
VDR gene variants associate with cognitive function and depressive symptoms in old age
-
Kuningas M, Mooijaart SP, Jolles J, Slagboom PE, Westendorp RGJ, Van Heemst D: VDR gene variants associate with cognitive function and depressive symptoms in old age. Neurobiol Aging 2009; 30: 466-473.
-
(2009)
Neurobiol Aging
, vol.30
, pp. 466-473
-
-
Kuningas, M.1
Mooijaart, S.P.2
Jolles, J.3
Slagboom, P.E.4
Westendorp, R.G.J.5
Van Heemst, D.6
-
18
-
-
84455191654
-
Vitamin D receptor and megalin gene polymorphisms and their associations with longitudinal cognitive change in US adults
-
Beydoun MA, Ding EL, Beydoun HA, Tanaka T, Ferrucci L, Zonderman AB: Vitamin D receptor and megalin gene polymorphisms and their associations with longitudinal cognitive change in US adults. Am J Clin Nutr 2012; 95: 163-178.
-
(2012)
Am J Clin Nutr
, vol.95
, pp. 163-178
-
-
Beydoun, M.A.1
Ding, E.L.2
Beydoun, H.A.3
Tanaka, T.4
Ferrucci, L.5
Zonderman, A.B.6
-
19
-
-
80054006421
-
The vitamin D receptor gene is associated with Alzheimer's disease
-
Lehmann DJ, Refsum H, Warden DR, Medway C, Wilcock GK, Smith DA: The vitamin D receptor gene is associated with Alzheimer's disease. Neurosci Lett 2011; 504: 79-82.
-
(2011)
Neurosci Lett
, vol.504
, pp. 79-82
-
-
Lehmann, D.J.1
Refsum, H.2
Warden, D.R.3
Medway, C.4
Wilcock, G.K.5
Smith, D.A.6
-
20
-
-
58049200536
-
Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer's disease
-
Beecham GW, Martin ER, Li YJ, Slifer MA, Gilbert JR, Haines JL, Pericak-Vance MA: Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer's disease. Am J Hum Genet 2009; 84: 35-43.
-
(2009)
Am J Hum Genet
, vol.84
, pp. 35-43
-
-
Beecham, G.W.1
Martin, E.R.2
Li, Y.J.3
Slifer, M.A.4
Gilbert, J.R.5
Haines, J.L.6
Pericak-Vance, M.A.7
-
21
-
-
79851478250
-
Vitamin D receptor gene as a candidate gene for Parkinson's disease
-
Butler MW, Burt A, Edwards TL, Zuchner S, Scott WK, Martin ER, Vance JM, Wang L: Vitamin D receptor gene as a candidate gene for Parkinson's disease. Ann Hum Genet 2011; 75: 201-210.
-
(2011)
Ann Hum Genet
, vol.75
, pp. 201-210
-
-
Butler, M.W.1
Burt, A.2
Edwards, T.L.3
Zuchner, S.4
Scott, W.K.5
Martin, E.R.6
Vance, J.M.7
Wang, L.8
-
22
-
-
84867850716
-
Vitamin D receptor gene haplotype is associated with late-onset Alzheimer's disease
-
Gezen-Ak D, Dursun E, Bilgiç B, Hanaasi H, Ertan T, Gürvit H, Emre M, Eker E, Ulutin T, Uysal Ö, Yilmazer S: Vitamin D receptor gene haplotype is associated with late-onset Alzheimer's disease. Tohoku J Exp Med 2012; 228: 189-196.
-
(2012)
Tohoku J Exp Med
, vol.228
, pp. 189-196
-
-
Gezen-Ak, D.1
Dursun, E.2
Bilgiç, B.3
Hanaasi, H.4
Ertan, T.5
Gürvit, H.6
Emre, M.7
Eker, E.8
Ulutin, T.9
Uysal Ö.10
Yilmazer, S.11
-
23
-
-
67349140353
-
Premature aging in vitamin D receptor mutant mice
-
Keisala TMA, Lou YR, Zou J, Kalueff AV, Pyykkö I, Tuohimaa P: Premature aging in vitamin D receptor mutant mice. J Steroid Biochem Mol Biol 2009; 115: 91-97.
-
(2009)
J Steroid Biochem Mol Biol
, vol.115
, pp. 91-97
-
-
Keisala, T.M.A.1
Lou, Y.R.2
Zou, J.3
Kalueff, A.V.4
Pyykkö, I.5
Tuohimaa, P.6
-
24
-
-
74049145706
-
Association of vitamin D deficiency with cognitive impairment in older women: Cross-sectional study
-
Annweiler C, Schott AM, Allali G, Bridenbaugh SA, Kressig RW, Allain P, Herrmann FR, Beauchet O: Association of vitamin D deficiency with cognitive impairment in older women: cross-sectional study. Neurology 2010; 74: 27-32.
-
(2010)
Neurology
, vol.74
, pp. 27-32
-
-
Annweiler, C.1
Schott, A.M.2
Allali, G.3
Bridenbaugh, S.A.4
Kressig, R.W.5
Allain, P.6
Herrmann, F.R.7
Beauchet, O.8
-
25
-
-
46849087567
-
Hypovitaminosis D in the elderly: From bone to brain
-
Cherniack EP, Florez H, Roos BA, Troen BR, Levis S: Hypovitaminosis D in the elderly: from bone to brain. J Nutr Health Aging 2008; 12: 366-373.
-
(2008)
J Nutr Health Aging
, vol.12
, pp. 366-373
-
-
Cherniack, E.P.1
Florez, H.2
Roos, B.A.3
Troen, B.R.4
Levis, S.5
-
26
-
-
54049152001
-
Prevalence of vitamin D insufficiency in patients with Parkinson's disease and Alzheimer's disease
-
Evatt ML, DeLong MR, Khazai N, Rosen A, Triche S, Tangpricha V: Prevalence of vitamin D insufficiency in patients with Parkinson's disease and Alzheimer's disease. Arch Neurol 2008; 65: 1348-1352.
-
(2008)
Arch Neurol
, vol.65
, pp. 1348-1352
-
-
Evatt, M.L.1
Delong, M.R.2
Khazai, N.3
Rosen, A.4
Triche, S.5
Tangpricha, V.6
-
28
-
-
77954600272
-
Vitamin D and risk of cognitive decline in elderly persons
-
Llewellyn DJ, Lang IA, Langa KM, Muniz-Terrera G, Phillips CL, Cherubini A, Ferrucci L, Melzer D: Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med 2010; 170: 1135-1141.
-
(2010)
Arch Intern Med
, vol.170
, pp. 1135-1141
-
-
Llewellyn, D.J.1
Lang, I.A.2
Langa, K.M.3
Muniz-Terrera, G.4
Phillips, C.L.5
Cherubini, A.6
Ferrucci, L.7
Melzer, D.8
-
29
-
-
42049095896
-
Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction?
-
McCann J, Ames BN: Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction? FASEB J 2008; 22: 982-1001.
-
(2008)
FASEB J
, vol.22
, pp. 982-1001
-
-
McCann, J.1
Ames, B.N.2
-
30
-
-
33845598391
-
Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults
-
Wilkins CH, Sheline YI, Roe CM, Birge SJ, Morris JC: Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry 2006; 14: 1032-1040.
-
(2006)
Am J Geriatr Psychiatry
, vol.14
, pp. 1032-1040
-
-
Wilkins, C.H.1
Sheline, Y.I.2
Roe, C.M.3
Birge, S.J.4
Morris, J.C.5
-
31
-
-
84855883200
-
Serum vitamin D deficiency as a predictor of incident non-Alzheimer dementias: A 7-year longitudinal study
-
Annweiler C, Rolland Y, Schott AM, Blain H, Vellas B, Beauchet O: Serum vitamin D deficiency as a predictor of incident non-Alzheimer dementias: a 7-year longitudinal study. Dement Geriatr Cogn Disord 2012; 32: 273-278.
-
(2012)
Dement Geriatr Cogn Disord
, vol.32
, pp. 273-278
-
-
Annweiler, C.1
Rolland, Y.2
Schott, A.M.3
Blain, H.4
Vellas, B.5
Beauchet, O.6
-
32
-
-
84863091991
-
Vitamin D deficiency, cognitive impairment and dementia: A systematic review and meta-analysis
-
Etgen T, Sander D, Bickel H, Sander K, Förstl H: Vitamin D deficiency, cognitive impairment and dementia: a systematic review and meta-analysis. Dement Geriatr Cogn Disord 2012; 33: 297-305.
-
(2012)
Dement Geriatr Cogn Disord
, vol.33
, pp. 297-305
-
-
Etgen, T.1
Sander, D.2
Bickel, H.3
Sander, K.4
Förstl, H.5
-
33
-
-
46849117753
-
Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with Alzheimer's disease
-
Oudshoorn C, Mattace-Raso FUS, van der Velde N, Colin EM, van der Cammen TJM: Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with Alzheimer's disease. Dement Geriatr Cogn Disord 2008; 25: 539-543.
-
(2008)
Dement Geriatr Cogn Disord
, vol.25
, pp. 539-543
-
-
Oudshoorn, C.1
Mattace-Raso, F.U.S.2
Van Der Velde, N.3
Colin, E.M.4
Van Der Cammen, T.J.M.5
-
34
-
-
14844319301
-
Developmental vitamin D3 deficiency alters the adult rat brain
-
Féron F, Burne THJ, Brown J, Smith E, McGrath JJ, Mackay-Sima A, Eyles DW: Developmental vitamin D3 deficiency alters the adult rat brain. Brain Res Bull 2005; 65: 141-148.
-
(2005)
Brain Res Bull
, vol.65
, pp. 141-148
-
-
Féron, F.1
Burne, T.H.J.2
Brown, J.3
Smith, E.4
McGrath, J.J.5
Mackay-Sima, A.6
Eyles, D.W.7
-
35
-
-
79951563916
-
A novel perspective for Alzheimer's disease: Vitamin D receptor suppression by amyloid and preventing the amyloid induced alterations by vitamin D in cortical neurons
-
Dursun E, Gezen-Ak D, Yilmazer S: A novel perspective for Alzheimer's disease: vitamin D receptor suppression by amyloid and preventing the amyloid induced alterations by vitamin D in cortical neurons. J Alzheimers Dis 2011; 23: 207-219.
-
(2011)
J Alzheimers Dis
, vol.23
, pp. 207-219
-
-
Dursun, E.1
Gezen-Ak, D.2
Yilmazer, S.3
-
36
-
-
79960701615
-
Vitamin D3-enriched diet correlates with a decrease of amyloid plaques in the brain of A-PP transgenic mice
-
Yu J, Gattoni-Celli M, Zhu H, Bhat NR, Sambamurti K, Gattoni-Celli S, Kindy MS: Vitamin D3-enriched diet correlates with a decrease of amyloid plaques in the brain of A-PP transgenic mice. J Alzheimers Dis 2011; 25: 295-307.
-
(2011)
J Alzheimers Dis
, vol.25
, pp. 295-307
-
-
Yu, J.1
Gattoni-Celli, M.2
Zhu, H.3
Bhat, N.R.4
Sambamurti, K.5
Gattoni-Celli, S.6
Kindy, M.S.7
-
37
-
-
67849110353
-
1alpha,25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer's disease patients
-
Masoumi A, Goldenson B, Ghirmai S, Avagyan H, Zaghi J, Abel K, Zheng X, Espinosa-Jeffrey A, Mahanian M, Liu PT, Hewison M, Mizwickie M, Cashman J, Fiala M: 1alpha,25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer's disease patients. J Alzheimers Dis 2009; 17: 703-717.
-
(2009)
J Alzheimers Dis
, vol.17
, pp. 703-717
-
-
Masoumi, A.1
Goldenson, B.2
Ghirmai, S.3
Avagyan, H.4
Zaghi, J.5
Abel, K.6
Zheng, X.7
Espinosa-Jeffrey, A.8
Mahanian, M.9
Liu, P.T.10
Hewison, M.11
Mizwickie, M.12
Cashman, J.13
Fiala, M.14
-
38
-
-
84863249788
-
Genomic and nongenomic signaling induced by 1,25(OH)2-vitamin D3 promotes the recovery of amyloid phagocytosis by Alzheimer's disease macrophages
-
Mizwicki MT, Menegaz D, Zhang J, Barrientos-Durán A, Tse S, Cashman JR, Griffin PR, Fiala M: Genomic and nongenomic signaling induced by 1,25(OH)2-vitamin D3 promotes the recovery of amyloid phagocytosis by Alzheimer's disease macrophages. J Alzheimers Dis 2011; 29: 51-62.
-
(2011)
J Alzheimers Dis
, vol.29
, pp. 51-62
-
-
Mizwicki, M.T.1
Menegaz, D.2
Zhang, J.3
Barrientos-Durán, A.4
Tse, S.5
Cashman, J.R.6
Griffin, P.R.7
Fiala, M.8
-
39
-
-
84867878957
-
Neuroprotective and immune effects of active forms of vitamin D3 and docosahexaenoic acid in Alzheimer disease patients
-
Fiala M, Mizwicki MT: Neuroprotective and immune effects of active forms of vitamin D3 and docosahexaenoic acid in Alzheimer disease patients. Functional Foods Health Dis 2011; 12: 545-554.
-
(2011)
Functional Foods Health Dis
, vol.12
, pp. 545-554
-
-
Fiala, M.1
Mizwicki, M.T.2
-
40
-
-
79952303913
-
The effects of vitamin D receptor silencing on the expression of LVSCC-A1C and LVSCC-A1D and the release of NGF in cortical neurons
-
Gezen-Ak D, Dursun E, Yilmazer S: The effects of vitamin D receptor silencing on the expression of LVSCC-A1C and LVSCC-A1D and the release of NGF in cortical neurons. PLoS One 2011; 6:e17553.
-
(2011)
PLoS One
, vol.6
-
-
Gezen-Ak, D.1
Dursun, E.2
Yilmazer, S.3
-
41
-
-
0012795129
-
Serum-free media for neural cell cultures
-
Fedoroff S, Richardson A (eds) New York, Humana Press
-
Price P, Brewer GJ: Serum-free media for neural cell cultures; in Fedoroff S, Richardson A (eds): Protocols for Neural Cell Culture. New York, Humana Press, 1998, pp 255-264.
-
(1998)
Protocols for Neural Cell Culture
, pp. 255-264
-
-
Price, P.1
Brewer, G.J.2
-
42
-
-
0141960033
-
Amyloid induces paired helical filament-like tau filaments in tissue culture
-
Ferrari A, Hoerndli F, Baechi T, Nitsch RM, Götz J: Amyloid induces paired helical filament-like tau filaments in tissue culture. J Biol Chem 2003; 278: 40162-40168.
-
(2003)
J Biol Chem
, vol.278
, pp. 40162-40168
-
-
Ferrari, A.1
Hoerndli, F.2
Baechi, T.3
Nitsch, R.M.4
Götz, J.5
-
43
-
-
33847643776
-
Quantification of mRNA using real-time RT-PCR
-
Nolan T, Hands BE, Bustin SA: Quantification of mRNA using real-time RT-PCR. Nat Protoc 2006; 1: 1556-1582.
-
(2006)
Nat Protoc
, vol.1
, pp. 1556-1582
-
-
Nolan, T.1
Hands, B.E.2
Bustin, S.A.3
-
44
-
-
34249092704
-
Calcium and neurodegeneration
-
Mattson MP: Calcium and neurodegeneration. Aging Cell 2007; 6: 337-350.
-
(2007)
Aging Cell
, vol.6
, pp. 337-350
-
-
Mattson, M.P.1
-
45
-
-
80053906347
-
Calcium channel blocking as a therapeutic strategy for Alzheimer's disease: The case for isradipine
-
Anekonda TS, Quinn JF: Calcium channel blocking as a therapeutic strategy for Alzheimer's disease: the case for isradipine. Biochim Biophys Acta 2011; 1812: 1584-1590.
-
(2011)
Biochim Biophys Acta
, vol.1812
, pp. 1584-1590
-
-
Anekonda, T.S.1
Quinn, J.F.2
-
46
-
-
0034319190
-
Molecular mechanism of neurodegeneration induced by Alzheimer's beta-amyloid protein: Channel formation and disruption of calcium homeostasis
-
Kawahara M, Kuroda Y: Molecular mechanism of neurodegeneration induced by Alzheimer's beta-amyloid protein: channel formation and disruption of calcium homeostasis. Brain Res Bull 2000; 53: 389-397.
-
(2000)
Brain Res Bull
, vol.53
, pp. 389-397
-
-
Kawahara, M.1
Kuroda, Y.2
-
47
-
-
0028265912
-
Secondary structure of amyloid- peptide correlates with neurotoxic activity in vitro
-
Simmons L, May PC, Tomaselli KJ, Rydel RE, Fuson KS, Brigham EF, Wright S, Lieberburg I, Becker GW, Brems DN, Lieberburg IM, Li W: Secondary structure of amyloid- peptide correlates with neurotoxic activity in vitro. Mol Pharmacol 1994; 45: 373-379.
-
(1994)
Mol Pharmacol
, vol.45
, pp. 373-379
-
-
Simmons, L.1
May, P.C.2
Tomaselli, K.J.3
Rydel, R.E.4
Fuson, K.S.5
Brigham, E.F.6
Wright, S.7
Lieberburg, I.8
Becker, G.W.9
Brems, D.N.10
Lieberburg, I.M.11
Li, W.12
-
48
-
-
49449089402
-
-
Basel, Birkhäuser
-
Emilien G, Durlach C, Minaker KL, Winblad B, Gauthier S, Maloteaux JM: Alzheimer Disease: Neuropsychology and Pharmacology. Basel, Birkhäuser, 2004, pp 57-65.
-
(2004)
Alzheimer Disease: Neuropsychology and Pharmacology
, pp. 57-65
-
-
Emilien, G.1
Durlach, C.2
Minaker, K.L.3
Winblad, B.4
Gauthier, S.5
Maloteaux, J.M.6
-
49
-
-
0042536471
-
Neuronal and glial calcium signaling in Alzheimer's disease
-
Mattson MP, Chan SL: Neuronal and glial calcium signaling in Alzheimer's disease. Cell Calcium 2003; 34: 385-397.
-
(2003)
Cell Calcium
, vol.34
, pp. 385-397
-
-
Mattson, M.P.1
Chan, S.L.2
-
50
-
-
0032005805
-
4-hydroxynonenal, a lipid peroxidation product, inhibits glutamate transport in astrocytes
-
Blanc EM, Keller JN, Fernandez S, Mattson MP: 4-hydroxynonenal, a lipid peroxidation product, inhibits glutamate transport in astrocytes. Glia 1998; 22: 149-160.
-
(1998)
Glia
, vol.22
, pp. 149-160
-
-
Blanc, E.M.1
Keller, J.N.2
Fernandez, S.3
Mattson, M.P.4
-
51
-
-
0028981159
-
Amyloid beta-peptide impairs ion-motive ATPase activities: Evidence for a role in loss of neuronal Ca 2+ homeostasis and cell death
-
Mark RJ, Hensley K, Butterfield DA, Mattson MP: Amyloid beta-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca 2+ homeostasis and cell death. J Neurosci 1995; 15: 6239-6249.
-
(1995)
J Neurosci
, vol.15
, pp. 6239-6249
-
-
Mark, R.J.1
Hensley, K.2
Butterfield, D.A.3
Mattson, M.P.4
-
52
-
-
0031020993
-
Amyloid beta-peptide impairs glucose uptake in hippocampal and cortical neurons: Involvement of membrane lipid peroxidation
-
Mark RJ, Pang Z, Geddes JW, Mattson MP: Amyloid beta-peptide impairs glucose uptake in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J Neurosci 1997; 17: 1046-1054.
-
(1997)
J Neurosci
, vol.17
, pp. 1046-1054
-
-
Mark, R.J.1
Pang, Z.2
Geddes, J.W.3
Mattson, M.P.4
-
53
-
-
12844274439
-
Pharmacological treatment of neuropsychiatric symptoms of dementia: A review of the evidence
-
Sink K, Holden KF, Yaffe K: Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA 2005; 293: 596-608.
-
(2005)
JAMA
, vol.293
, pp. 596-608
-
-
Sink, K.1
Holden, K.F.2
Yaffe, K.3
-
54
-
-
33745027879
-
Molecular mechanisms for Alzheimer's disease: Implications for neuroimaging and therapeutics
-
Masters C, Cappai R, Barnham KJ, Villemagne VL: Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics. J Neurochem 2006; 97: 1700-1725.
-
(2006)
J Neurochem
, vol.97
, pp. 1700-1725
-
-
Masters, C.1
Cappai, R.2
Barnham, K.J.3
Villemagne, V.L.4
-
55
-
-
21044458854
-
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer's disease
-
Tuszynski MH, Thal L, Pay M, Salmon DP, Sang U H, Bakay R, Patel P, Blesch A Vahlsing HL, Ho G, Tong G, Potkin SG, Fallon J, Hansen L, Mufson E, Kordower JH, Gall C, Conner J: A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer's disease. Nat Med 2005; 11: 551-555.
-
(2005)
Nat Med
, vol.11
, pp. 551-555
-
-
Tuszynski, M.H.1
Thal, L.2
Pay, M.3
Salmon, D.P.4
Sang, U.H.5
Bakay, R.6
Patel, P.7
Blesch, A.8
Vahlsing, H.L.9
Ho, G.10
Tong, G.11
Potkin, S.G.12
Fallon, J.13
Hansen, L.14
Mufson, E.15
Kordower, J.H.16
Gall, C.17
Conner, J.18
|